[4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate

C18H17BrFN7O7S — CID 176517322

IUPAC[4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate
SMILESNC(=O)OS(=O)(=O)NC1CCC(Nc2nonc2C2=NOC(=C=O)N2c2ccc(F)c(Br)c2)CC1
InChIInChI=1S/C18H17BrFN7O7S/c19-12-7-11(5-6-13(12)20)27-14(8-28)32-25-17(27)15-16(24-34-23-15)22-9-1-3-10(4-2-9)26-35(30,31)33-18(21)29/h5-7,9-10,26H,1-4H2,(H2,21,29)(H,22,24)
InChIKeyXLEZNRXEILHUAK-UHFFFAOYSA-N
MW574.35 g/mol
LogP1.50
Rot. Bonds7

About [4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate

[4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate (PubChem CID 176517322) has the molecular formula C18H17BrFN7O7S and a molecular weight of 574.35 g/mol. Its IUPAC name is [4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate.

Molecular Properties

Compound Name[4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate
PubChem CID176517322
Molecular FormulaC18H17BrFN7O7S
Molecular Weight574.35 g/mol
Exact Mass573.01
IUPAC Name[4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate
SMILESNC(=O)OS(=O)(=O)NC1CCC(Nc2nonc2C2=NOC(=C=O)N2c2ccc(F)c(Br)c2)CC1
InChIInChI=1S/C18H17BrFN7O7S/c19-12-7-11(5-6-13(12)20)27-14(8-28)32-25-17(27)15-16(24-34-23-15)22-9-1-3-10(4-2-9)26-35(30,31)33-18(21)29/h5-7,9-10,26H,1-4H2,(H2,21,29)(H,22,24)
InChIKeyXLEZNRXEILHUAK-UHFFFAOYSA-N
XLogP1.50
TPSA191.34 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds7
Heavy Atoms35
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500574.35
LogP ≤ 51.50
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'ketene', 'substructure': 'N/A'}

Analyze [4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate?
The IUPAC name of [4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate (CID 176517322) is [4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate.
What is the SMILES notation for [4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate?
The canonical SMILES for [4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate is NC(=O)OS(=O)(=O)NC1CCC(Nc2nonc2C2=NOC(=C=O)N2c2ccc(F)c(Br)c2)CC1.
What is the InChIKey of [4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate?
The InChIKey is XLEZNRXEILHUAK-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H17BrFN7O7S/c19-12-7-11(5-6-13(12)20)27-14(8-28)32-25-17(27)15-16(24-34-23-15)22-9-1-3-10(4-2-9)26-35(30,31)33-18(21)29/h5-7,9-10,26H,1-4H2,(H2,21,29)(H,22,24).
What are the key properties of [4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate?
[4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate has a molecular weight of 574.35 g/mol, XLogP of 1.50, 7 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[4-[4-(3-bromo-4-fluorophenyl)-5-(oxomethylidene)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]cyclohexyl]sulfamoyl carbamate is sourced from PubChem (CID 176517322), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).